56 Trending Stocks

Fri, Dec 4, 2020

China Biologic Products Holdings Inc

CBPO 118.53
0.11 (0.1%)

Open: 118.70 High: 118.70 Low: 118.31

9 x 118.53 = 1066.77
x $118.53 =

NASDAQ: CBPO $5 Billion Mid-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 0%. 1 Year Return 2%. 2020 YTD Return 1%. Since Earnings 0%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $97.91

The 52 Week Low is $97.91 set on Mon, Apr 6, 2020.

52WH $119.29

The 52 Week High is $119.29 set on Mon, Nov 30, 2020.

ATH $143.21

The All-Time High is $143.21 set on Thu, Dec 31, 2015.

52 Week Range

$97.91
$119.29
Apr 6, 2020
Nov 30, 2020

Earnings

1.38

Earnings Per Share

44.33

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Mon, Aug 17, 2020

Since Q2 Earnings Report

CBPO 9.7%


Q3 Earnings for Jul, Aug & Sep

Tue, Nov 24, 2020

Since Q3 Earnings Report

CBPO 0.0%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

China Biologic Products Holdings Inc trades on the NASDAQ. CBPO's market cap is 4.6 Billion.

China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.

Website

Related Channels

Account Channels

Track your portfolio and more.